Abstract:ID 21668 Poster Board 454 Background: Chronic kidney disease (CKD) is a progressive disease characterized by gradual loss of kidney function over time. Diabetes, hypertension, and obesity are the leading risk factors for developing CKD. Fibrosis is regarded as the final common pathway leading to CKD due to the irreversible damage it causes to the nephrons. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors (Dapagliflozin and Canagliflozin) have been shown to be renoprotective in type 2 diabetes patients. … Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.